Tildrakizumab as a potential long‐term therapeutic agent for severe Hidradenitis Suppurativa: A 15 months experience of an Australian institution.
| Autor: | Kok, Yonatan1 (AUTHOR) yonathan.kok@gmail.com, Nicolopoulos, Jenny1 (AUTHOR), Dolianitis, Con1 (AUTHOR) |
|---|---|
| Zdroj: | Australasian Journal of Dermatology. May2021, Vol. 62 Issue 2, pe313-e316. 4p. 2 Charts. |
| Databáze: | Academic Search Ultimate |
| Externí odkaz: |
|